CompletedPHASE1, PHASE2NCT05636904

Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men

Studying Alopecia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Dermaliq Therapeutics, Inc.
Principal Investigator
Betsy Hughes-Formella, PhD
Dermaliq Therapeutics, Inc.
Intervention
prostaglandin F2a analogue in vehicle solution high dose(drug)
Enrollment
120 enrolled
Eligibility
18-60 years · MALE
Timeline
2022 – 2024

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05636904 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia →

← Back to all trials